The Epstein–Barr virus (EBV) is a DNA lymphotropic herpesvirus and the causative agent of
infectious mononucleosis. EBV is highly prevalent since it affects more than 90% of …

Abstract Latent Epstein–Barr virus (EBV) infection has a substantial role in causing many
human disorders. The persistence of these viral genomes in all malignant cells, yet with the …

EBV was the first human virus to be directly implicated in carcinogenesis. It infects> 90% of
the world's population. Although most humans coexist with the virus without serious …

Epstein–Barr virus (EBV) is the first identified human oncogenic virus that can establish
asymptomatic life-long persistence. It is associated with a large spectrum of diseases …

Herpesviruses have evolved exquisite virus-host interactions that co-opt or evade a number
of host pathways to enable the viruses to persist. Persistence of human cytomegalovirus …

Epstein–Barr virus (EBV) is consistently detected in nasopharyngeal carcinoma (NPC) from
regions of high and low incidence. EBV DNA within the tumor is homogeneous with regard …

Abstract Latent membrane protein 1 (LMP1) of Epstein–Barr virus (EBV) is an integral
membrane protein which has transforming potential and is necessary but not sufficient for B …

The tumor necrosis factor receptor (TNFR) superfamily represents a growing family, with
over 20 members having been identified thus far in mammalian cells. These proteins share …

The latent membrane protein 1 (LMP1) of the Epstein–Barr virus has transforming properties
in rodent fibroblasts and is expressed in most of the cancers associated with Epstein–Barr …

Epstein-Barr virus (EBV) is a ubiquitous gammaherpesvirus which asymptomatically infects
the majority of the world population. Under immunocompromised conditions, EBV can …